These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26476399)

  • 21. E/e' ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction.
    Lu DY; Haileselassie B; Ventoulis I; Liu HY; Liang HY; Pozios I; Canepa M; Phillip S; Abraham MR; Abraham T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):101-107. PubMed ID: 28977350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful MACE risk stratification in hypertrophic cardiomyopathy patients using different 2D speckle-tracking TTE approaches.
    Ozawa K; Funabashi N; Takaoka H; Kobayashi Y
    Int J Cardiol; 2017 Feb; 228():1015-1021. PubMed ID: 27931009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features of the systolic anterior motion of the mitral valve among patients without hypertrophic cardiomyopathy.
    Uematsu S; Takaghi A; Imamura Y; Ashihara K; Hagiwara N
    J Cardiol; 2017 Feb; 69(2):495-500. PubMed ID: 27241937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doppler-derived left ventricular negative dP/dt as a predictor of atrial fibrillation or ischemic stroke in patients with degenerative mitral regurgitation and normal ejection fraction.
    Yi JE; Lee DH; Cho EJ; Jeon HK; Jung HO; Youn HJ
    Echocardiography; 2014 Mar; 31(3):285-92. PubMed ID: 24007645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of a comprehensive exercise echocardiography assessment for patients with hypertrophic cardiomyopathy.
    Peteiro J; Barriales-Villa R; Larrañaga-Moreira JM; Bouzas-Mosquera A; Martinez-Veira C; Castro-Dios D; Fernández-Fernández X; Monserrat L; Vazquez-Rodriguez J
    J Cardiol; 2021 May; 77(5):525-531. PubMed ID: 33341337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitral regurgitation in heart failure: insights from CPET combined with exercise echocardiography.
    Bandera F; Generati G; Pellegrino M; Garatti A; Labate V; Alfonzetti E; Gaeta M; Castelvecchio S; Menicanti L; Guazzi M
    Eur Heart J Cardiovasc Imaging; 2017 Mar; 18(3):296-303. PubMed ID: 27194781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between outflow obstruction and left ventricular functional impairment in hypertrophic cardiomyopathy: a Doppler echocardiographic study.
    Araujo AQ; Arteaga E; Ianni BM; Fernandes F; Ramires FJ; Buck PC; Salemi VM; Nastari L; Mady C
    Echocardiography; 2006 Oct; 23(9):734-40. PubMed ID: 16999691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
    Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
    J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy.
    Ong KC; Geske JB; Hebl VB; Nishimura RA; Schaff HV; Ackerman MJ; Klarich KW; Siontis KC; Coutinho T; Dearani JA; Ommen SR; Gersh BJ
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):604-10. PubMed ID: 26922089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aortic stiffness independently predicts exercise capacity in hypertrophic cardiomyopathy: a multimodality imaging study.
    Austin BA; Popovic ZB; Kwon DH; Thamilarasan M; Boonyasirinant T; Flamm SD; Lever HM; Desai MY
    Heart; 2010 Aug; 96(16):1303-10. PubMed ID: 20659950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long mitral valve leaflets determine left ventricular outflow tract obstruction during exercise in hypertrophic cardiomyopathy.
    Henein M; Arvidsson S; Pilebro B; Backman C; Mörner S; Lindqvist P
    Int J Cardiol; 2016 Jun; 212():47-53. PubMed ID: 27031819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time based versus strain based myocardial performance indices in hypertrophic cardiomyopathy, the merging role of left atrial strain.
    Kobayashi Y; Moneghetti KJ; Bouajila S; Stolfo D; Finocchiaro G; Kuznetsova T; Liang D; Schnittger I; Ashley E; Wheeler M; Haddad F
    Eur Heart J Cardiovasc Imaging; 2019 Mar; 20(3):334-342. PubMed ID: 30060097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4D flow MRI left atrial kinetic energy in hypertrophic cardiomyopathy is associated with mitral regurgitation and left ventricular outflow tract obstruction.
    Gupta AN; Soulat G; Avery R; Allen BD; Collins JD; Choudhury L; Bonow RO; Carr J; Markl M; Elbaz MSM
    Int J Cardiovasc Imaging; 2021 Sep; 37(9):2755-2765. PubMed ID: 33523363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of exercise capacity in predicting outcomes and determining optimal timing of surgery in significant primary mitral regurgitation.
    Naji P; Griffin BP; Barr T; Asfahan F; Gillinov AM; Grimm RA; Rodriguez LL; Mihaljevic T; Stewart WJ; Desai MY
    J Am Heart Assoc; 2014 Sep; 3(5):e001010. PubMed ID: 25213567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
    Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
    Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
    Kitaoka H; Kubo T; Hayashi K; Yamasaki N; Matsumura Y; Furuno T; Doi YL
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):544-9. PubMed ID: 23060455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
    Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation.
    Kusunose K; Popović ZB; Motoki H; Marwick TH
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):167-76. PubMed ID: 23357242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of mitral regurgitation assessment during exercise echocardiography in patients with left ventricular dysfunction: a follow-up study of 1.7 +/- 1.5 years.
    Peteiro J; Bendayan I; Mariñas J; Campos R; Bouzas B; Castro-Beiras A
    Eur J Echocardiogr; 2008 Jan; 9(1):18-25. PubMed ID: 17241820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and implications of mitral regurgitation using cMRI in patients with hypertrophic cardiomyopathy.
    Muresan ID; Agoston R; Serban A; Mot SCD; Costea S; Zlibut A; Orzan RI; Cojan-Minzat BO; Cionca C; Horvat D; Agoston-Coldea L
    Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4006-4018. PubMed ID: 37203824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.